Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases.

MLA

Song, Feizhi, et al. “Cleavage Site-Directed Antibodies Reveal the Prion Protein in Humans Is Shed by ADAM10 at Y226 and Associates with Misfolded Protein Deposits in Neurodegenerative Diseases.” Acta Neuropathologica, vol. 148, no. 1, July 2024, pp. 1–33. EBSCOhost, https://doi.org/10.1007/s00401-024-02763-5.

APA

Song, F., Kovac, V., Mohammadi, B., Littau, J. L., Scharfenberg, F., Matamoros Angles, A., Vanni, I., Shafiq, M., Orge, L., Galliciotti, G., Djakkani, S., Linsenmeier, L., Černilec, M., Hartman, K., Jung, S., Tatzelt, J., Neumann, J. E., Damme, M., Tschirner, S. K., & Lichtenthaler, S. F. (2024). Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases. Acta Neuropathologica, 148(1), 1–33. https://doi.org/10.1007/s00401-024-02763-5

Chicago

Song, Feizhi, Valerija Kovac, Behnam Mohammadi, Jessica L. Littau, Franka Scharfenberg, Andreu Matamoros Angles, Ilaria Vanni, et al. 2024. “Cleavage Site-Directed Antibodies Reveal the Prion Protein in Humans Is Shed by ADAM10 at Y226 and Associates with Misfolded Protein Deposits in Neurodegenerative Diseases.” Acta Neuropathologica 148 (1): 1–33. doi:10.1007/s00401-024-02763-5.